EGFR-independent EGFR-mutant lung adenocarcinoma cells depend on Bcl-xL and MCL1 for survival
Author:
Funder
Japan Society for the Promotion of Science
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference15 articles.
1. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer;Pao;Nat. Rev. Canc.,2010
2. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer;Leonetti;Br. J. Canc.,2019
3. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC;Ramalingam;N. Engl. J. Med.,2020
4. Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells, Lab;Sakuma;Invest,2013
5. Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial-mesenchymal transition phenotype;Sakuma;Lab. Invest.,2016
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Non-viral vectors combined delivery of siRNA and anti-cancer drugs to reverse tumor multidrug resistance;Biomedicine & Pharmacotherapy;2024-09
2. Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer;Cell Death & Disease;2024-08-09
3. Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells;Biochemical and Biophysical Research Communications;2023-10
4. Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin‐siRNA Lipoplexes for the Treatment of Lung and Breast Cancers**;ChemMedChem;2023-07-06
5. Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells;Biochemical and Biophysical Research Communications;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3